On the public citation graph
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
0 signed · 1101 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archsurg.1995.01430020088017openalex-snapshot
Hospital Mortality of Major Hepatectomy for Hepatocellular Carcinoma Associated With Cirrhosis
inferredcites →https://doi.org/10.1001/jama.2014.7189openalex-snapshot
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
inferredcites →https://doi.org/10.1001/jamaoncol.2015.2189openalex-snapshot
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1001/jamaoncol.2015.5252openalex-snapshot
Emergency Department–Initiated Palliative Care in Advanced Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2016.3147openalex-snapshot
MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1001/jamaoncol.2017.2303openalex-snapshot
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
inferredcites →https://doi.org/10.1001/jamaoncol.2017.5847openalex-snapshot
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19960501)77:9<1792::aid-cncr6>3.0.co;2-eopenalex-snapshot
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970601)79:11<2087::aid-cncr5>3.0.co;2-mopenalex-snapshot
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction
inferredcites →https://doi.org/10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0openalex-snapshot
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
inferredcites →https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6openalex-snapshot
Reporting results of cancer treatment
inferredcites →https://doi.org/10.1002/1097-0142(19840201)53:3<401::aid-cncr2820530306>3.0.co;2-lopenalex-snapshot
Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy
inferredcites →https://doi.org/10.1002/1097-0142(19851215)56:12<2751::aid-cncr2820561205>3.0.co;2-oopenalex-snapshot
Adriamycin treatment for hepatocellular carcinoma experience with 109 patients
inferredcites →https://doi.org/10.1002/1097-0142(19920215)69:4<925::aid-cncr2820690415>3.0.co;2-gopenalex-snapshot
Percutaneous etharrol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients
inferredcites →https://doi.org/10.1002/1097-0142(20000815)89:4<750::aid-cncr5>3.0.co;2-ropenalex-snapshot
Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/14651858.cd002799.pub2openalex-snapshot
Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B
inferredcites →https://doi.org/10.1002/14651858.cd008951.pub2openalex-snapshot
Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity
inferredcites →https://doi.org/10.1002/14651858.cd011650.pub2openalex-snapshot
Management of people with early- or very early-stage hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/bjs.10438openalex-snapshot
Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study)
inferredcites →https://doi.org/10.1002/bjs.10597openalex-snapshot
Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/bjs.10677openalex-snapshot
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/bjs.1800600817openalex-snapshot
Transection of the oesophagus for bleeding oesophageal varices
inferredcites →https://doi.org/10.1002/bjs.1800820141openalex-snapshot
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
inferredcites →https://doi.org/10.1002/bjs.4763openalex-snapshot
Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
inferredcites →https://doi.org/10.1002/bjs.7601openalex-snapshot
Comparison of open and laparoscopic live donor left lateral sectionectomy
inferredcites →https://doi.org/10.1002/bjs.9022openalex-snapshot
Improving outcomes of living-donor right hepatectomy
inferredcites →https://doi.org/10.1002/bjs.9960openalex-snapshot
Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas
inferredcites →https://doi.org/10.1002/cam4.476openalex-snapshot
Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
inferredcites →https://doi.org/10.1002/cam4.936openalex-snapshot
Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation
inferredcites →https://doi.org/10.1002/cld.568openalex-snapshot
Statins and metformin for chemoprevention of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.10557openalex-snapshot
Viral load is a significant prognostic factor for hepatitis B virus‐associated hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.20368openalex-snapshot
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma
inferredcites →https://doi.org/10.1002/cncr.21043openalex-snapshot
Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.21811openalex-snapshot
Radiation therapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.23684openalex-snapshot
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
inferredcites →https://doi.org/10.1002/cncr.24050openalex-snapshot
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.24300openalex-snapshot
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy
inferredcites →https://doi.org/10.1002/cncr.24619openalex-snapshot
Proton beam therapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.25314openalex-snapshot
Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.25809openalex-snapshot
The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial
inferredcites →https://doi.org/10.1002/cncr.25960openalex-snapshot
Hepatocellular carcinoma with extrahepatic metastasis
inferredcites →https://doi.org/10.1002/cncr.26134openalex-snapshot
Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.27533openalex-snapshot
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
inferredcites →https://doi.org/10.1002/cncr.29537openalex-snapshot
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
inferredcites →https://doi.org/10.1002/cncr.30008openalex-snapshot
Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
inferredcites →https://doi.org/10.1002/cncr.30816openalex-snapshot
Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
inferredcites →https://doi.org/10.1002/hep.1840140510openalex-snapshot
Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses
inferredcites →https://doi.org/10.1002/hep.1840160122openalex-snapshot
Natural History of Small Untreated Hepatocellular Carcinoma in Cirrhosis: A Multivariate Analysis of Prognostic Factors of Tumor Growth Rate and Patient Survival
inferredcites →https://doi.org/10.1002/hep.1840160212openalex-snapshot
Tumor Size Determines the Efficacy of Percutaneous Ethanol Injection for the Treatment of Small Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/hep.20728openalex-snapshot
Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *
inferredcites →https://doi.org/10.1002/hep.20933openalex-snapshot
Management of Hepatocellular Carcinoma *
inferredcites →https://doi.org/10.1002/hep.20948openalex-snapshot
Acetaminophen‐induced acute liver failure
inferredcites →https://doi.org/10.1002/hep.21024openalex-snapshot
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization
inferredcites →https://doi.org/10.1002/hep.21933openalex-snapshot
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
inferredcites →https://doi.org/10.1002/hep.21966openalex-snapshot
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.22412openalex-snapshot
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
inferredcites →https://doi.org/10.1002/hep.22648openalex-snapshot
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #
inferredcites →https://doi.org/10.1002/hep.23466openalex-snapshot
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.23725openalex-snapshot
Loco‐regional treatment of hepatocellular carcinoma†
inferredcites →https://doi.org/10.1002/hep.23965openalex-snapshot
Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study
inferredcites →https://doi.org/10.1002/hep.24199openalex-snapshot
Management of Hepatocellular Carcinoma: An Update Δσ
inferredcites →https://doi.org/10.1002/hep.24231openalex-snapshot
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation
inferredcites →https://doi.org/10.1002/hep.24246openalex-snapshot
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas
inferredcites →https://doi.org/10.1002/hep.24451openalex-snapshot
Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
inferredcites →https://doi.org/10.1002/hep.24545openalex-snapshot
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
inferredcites →https://doi.org/10.1002/hep.24638openalex-snapshot
Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?
inferredcites →https://doi.org/10.1002/hep.26014openalex-snapshot
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
inferredcites →https://doi.org/10.1002/hep.26256openalex-snapshot
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.26301openalex-snapshot
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
inferredcites →https://doi.org/10.1002/hep.26586openalex-snapshot
Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design
inferredcites →https://doi.org/10.1002/hep.27548openalex-snapshot
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.27752openalex-snapshot
Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria
inferredcites →https://doi.org/10.1002/hep.28280openalex-snapshot
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
inferredcites →https://doi.org/10.1002/hep.28453openalex-snapshot
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
inferredcites →https://doi.org/10.1002/hep.28600openalex-snapshot
Randomized, open‐label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.29086openalex-snapshot
AASLD guidelines for the treatment of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.29098openalex-snapshot
Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis
inferredcites →https://doi.org/10.1002/hep.29225openalex-snapshot
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey
inferredcites →https://doi.org/10.1002/hep.29318openalex-snapshot
Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
inferredcites →https://doi.org/10.1002/hep.29321openalex-snapshot
Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population
inferredcites →https://doi.org/10.1002/hep.29403openalex-snapshot
A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization
inferredcites →https://doi.org/10.1002/hep.510300629openalex-snapshot
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
inferredcites →https://doi.org/10.1002/hep.510310111openalex-snapshot
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/ijc.25864openalex-snapshot
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
inferredcites →https://doi.org/10.1002/jhbp.405openalex-snapshot
Comparison of laparoscopic major hepatectomy with propensity score matched open cases from the National Clinical Database in Japan
inferredcites →https://doi.org/10.1002/jhbp.502openalex-snapshot
Comparison of anatomic and non‐anatomic hepatic resection for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/jso.21631openalex-snapshot
Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/jso.24245openalex-snapshot
Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/jso.2930500104openalex-snapshot
Bone metastases of hepatocellular carcinoma after liver resection
inferredcites →https://doi.org/10.1002/lt.20035openalex-snapshot
Major liver resections for hepatocellular carcinoma on cirrhosis: Early and long-term outcomes
inferredcites →https://doi.org/10.1002/lt.20044openalex-snapshot
The surgical approach to HCC: Our progress and results in Japan
inferredcites →https://doi.org/10.1002/lt.20128openalex-snapshot
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
inferredcites →https://doi.org/10.1002/lt.20418openalex-snapshot
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.20526openalex-snapshot
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
inferredcites →https://doi.org/10.1002/lt.20636openalex-snapshot
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era
inferredcites →https://doi.org/10.1002/lt.20670openalex-snapshot
Recipient deaths during donor surgery: A new ethical problem in living donor liver transplantation (LDLT)
inferredcites →https://doi.org/10.1002/lt.20734openalex-snapshot
Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe
inferredcites →https://doi.org/10.1002/lt.21030openalex-snapshot
Three-Quarters of Right Liver Donors Experienced Postoperative Complications† ‡
inferredcites →https://doi.org/10.1002/lt.21281openalex-snapshot
Expansion of Selection Criteria for Patients with Hepatocellular Carcinoma in Living Donor Liver Transplantation
inferredcites →https://doi.org/10.1002/lt.21445openalex-snapshot
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
inferredcites →https://doi.org/10.1002/lt.21778openalex-snapshot
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data
inferredcites →https://doi.org/10.1002/lt.21999openalex-snapshot
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
inferredcites →https://doi.org/10.1002/lt.22336openalex-snapshot
Which matters most: Number of tumors, size of the largest tumor, or total tumor volume?
inferredcites →https://doi.org/10.1002/lt.22365openalex-snapshot
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
inferredcites →https://doi.org/10.1002/lt.22369openalex-snapshot
Imaging diagnosis and staging of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.22441openalex-snapshot
Sirolimus-Based Immunosuppression in Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/lt.23490openalex-snapshot
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: A meta-analysis
inferredcites →https://doi.org/10.1002/lt.24169openalex-snapshot
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
inferredcites →https://doi.org/10.1002/lt.24778openalex-snapshot
Donor safety in living donor liver transplantation: The Korean organ transplantation registry study
inferredcites →https://doi.org/10.1002/ssu.10043openalex-snapshot
Conformal chemoradiation for primary and metastatic liver malignancies
inferredcites →https://doi.org/10.1007/bf00542162openalex-snapshot
Naproxen disposition in patients with alcoholic cirrhosis
inferredcites →https://doi.org/10.1007/s00066-009-2020-xopenalex-snapshot
Proton-Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis*
inferredcites →https://doi.org/10.1007/s00066-014-0604-6openalex-snapshot
Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
inferredcites →https://doi.org/10.1007/s00228-008-0553-zopenalex-snapshot
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
inferredcites →https://doi.org/10.1007/s00228-009-0678-8openalex-snapshot
Pharmacokinetics and dosage adjustment in patients with renal dysfunction
inferredcites →https://doi.org/10.1007/s00261-015-0592-8openalex-snapshot
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00262-018-2247-4openalex-snapshot
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
inferredcites →https://doi.org/10.1007/s00268-005-0524-9openalex-snapshot
Portal Hypertension: Contraindication to Liver Surgery?
inferredcites →https://doi.org/10.1007/s00268-012-1845-0openalex-snapshot
Surgical Outcomes of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Korean Multicenter Study
inferredcites →https://doi.org/10.1007/s00268-013-1969-xopenalex-snapshot
Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study
inferredcites →https://doi.org/10.1007/s00268-015-3129-yopenalex-snapshot
Long‐Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥10 cm: Single‐Institution Experience with 471 Patients
inferredcites →https://doi.org/10.1007/s00268-017-4163-8openalex-snapshot
Bleeding Recurrence and Mortality Following Interventional Management of Spontaneous HCC Rupture: Results of a Multicenter European Study
inferredcites →https://doi.org/10.1007/s00270-007-9255-7openalex-snapshot
Transcatheter Arterial Chemoembolization (TACE) with Lipiodol to Treat Hepatocellular Carcinoma: Survey Results from the TACE Study Group of Japan
inferredcites →https://doi.org/10.1007/s00270-009-9711-7openalex-snapshot
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
inferredcites →https://doi.org/10.1007/s00270-012-0394-0openalex-snapshot
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
inferredcites →https://doi.org/10.1007/s00270-013-0656-5openalex-snapshot
Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology
inferredcites →https://doi.org/10.1007/s00270-013-0667-2openalex-snapshot
Comparison of Local Control in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma ≤6 cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography
inferredcites →https://doi.org/10.1007/s00270-014-1012-0openalex-snapshot
Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1007/s00270-016-1426-yopenalex-snapshot
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1007/s00270-017-1693-2openalex-snapshot
Erratum to: Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1007/s00280-009-1126-2openalex-snapshot
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00280-011-1616-xopenalex-snapshot
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
inferredcites →https://doi.org/10.1007/s00280-012-1993-9openalex-snapshot
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
inferredcites →https://doi.org/10.1007/s00330-007-0716-9openalex-snapshot
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions
inferredcites →https://doi.org/10.1007/s00330-009-1463-xopenalex-snapshot
Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients
inferredcites →https://doi.org/10.1007/s00330-015-3686-3openalex-snapshot
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
inferredcites →https://doi.org/10.1007/s00330-016-4207-8openalex-snapshot
Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial
inferredcites →https://doi.org/10.1007/s00330-017-4900-2openalex-snapshot
Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data
inferredcites →https://doi.org/10.1007/s00423-017-1609-2openalex-snapshot
Bridging to liver transplantation in HCC patients
inferredcites →https://doi.org/10.1007/s00432-004-0552-0openalex-snapshot
Randomized controlled trial of screening for hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00432-008-0496-xopenalex-snapshot
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area
inferredcites →https://doi.org/10.1007/s00432-013-1497-yopenalex-snapshot
A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy
inferredcites →https://doi.org/10.1007/s00534-005-1002-3openalex-snapshot
Systematic hepatectomy for small hepatocellular carcinoma in Korea
inferredcites →https://doi.org/10.1007/s005340100001openalex-snapshot
Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology
inferredcites →https://doi.org/10.1007/s00535-004-1427-5openalex-snapshot
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00535-006-1895-xopenalex-snapshot
Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00535-008-2244-zopenalex-snapshot
Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines
inferredcites →https://doi.org/10.1007/s00535-009-0033-yopenalex-snapshot
Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis
inferredcites →https://doi.org/10.1007/s00535-010-0278-5openalex-snapshot
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
inferredcites →https://doi.org/10.1007/s00535-011-0511-xopenalex-snapshot
Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00535-014-0978-3openalex-snapshot
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
inferredcites →https://doi.org/10.1007/s10147-014-0773-4openalex-snapshot
Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study
inferredcites →https://doi.org/10.1007/s10585-011-9442-4openalex-snapshot
Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s10620-017-4739-zopenalex-snapshot
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1007/s10637-014-0100-yopenalex-snapshot
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies
inferredcites →https://doi.org/10.1007/s10875-013-9976-0openalex-snapshot
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
inferredcites →https://doi.org/10.1007/s11060-008-9713-3openalex-snapshot
Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
inferredcites →https://doi.org/10.1007/s11060-014-1463-9openalex-snapshot
Clinical result of stereotactic radiosurgery for spinal metastasis from hepatocellular carcinoma: comparison with conventional radiation therapy
inferredcites →https://doi.org/10.1007/s11060-015-1926-7openalex-snapshot
Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study
inferredcites →https://doi.org/10.1007/s11605-012-1865-yopenalex-snapshot
Surgical Outcome of Right Liver Donors in Living Donor Liver Transplantation: Single-Center Experience with 500 Cases
inferredcites →https://doi.org/10.1007/s11605-012-2005-4openalex-snapshot
Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy
inferredcites →https://doi.org/10.1007/s11605-013-2302-6openalex-snapshot
Trends and Patterns of Utilization in Post-treatment Surveillance Imaging Among Patients Treated for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1007/s11605-015-2850-zopenalex-snapshot
Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
inferredcites →https://doi.org/10.1007/s12032-011-0145-0openalex-snapshot
Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification
inferredcites →https://doi.org/10.1007/s12032-012-0208-xopenalex-snapshot
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib
inferredcites →https://doi.org/10.1007/s12072-007-9020-7openalex-snapshot
Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s12072-007-9038-xopenalex-snapshot
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
inferredcites →https://doi.org/10.1007/s12072-008-9091-0openalex-snapshot
Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot study
inferredcites →https://doi.org/10.1007/s12072-011-9322-7openalex-snapshot
Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis
inferredcites →https://doi.org/10.1007/s12072-015-9675-4openalex-snapshot
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
inferredcites →https://doi.org/10.1007/s12072-017-9799-9openalex-snapshot
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
inferredcites →https://doi.org/10.1007/s12262-015-1261-4openalex-snapshot
Adjuvant Intrahepatic Injection Iodine-131-Lipiodol Improves Prognosis of Patients with Hepatocellular Carcinoma After Resection: a Meta-Analysis
inferredcites →https://doi.org/10.1007/s13277-012-0626-6openalex-snapshot
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study
inferredcites →https://doi.org/10.1016/0016-5085(85)90324-5openalex-snapshot
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
inferredcites →https://doi.org/10.1016/0016-5085(94)90419-7openalex-snapshot
Predictive factors for postoperative recurrence of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/0016-5085(95)90450-6openalex-snapshot
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.amjsurg.2013.06.009openalex-snapshot
Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma ≤5 cm without macrovascular invasion
inferredcites →https://doi.org/10.1016/j.asjsur.2013.09.001openalex-snapshot
Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation
inferredcites →https://doi.org/10.1016/j.blre.2008.02.001openalex-snapshot
Management of viral hepatitis in hematologic malignancies
inferredcites →https://doi.org/10.1016/j.bpg.2014.07.017openalex-snapshot
Role of antiviral treatment for HCC prevention
inferredcites →https://doi.org/10.1016/j.cgh.2006.05.027openalex-snapshot
Hepatitis B Virus Reactivation After Cytotoxic Chemotherapy: The Disease and Its Prevention
inferredcites →https://doi.org/10.1016/j.cgh.2008.08.005openalex-snapshot
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
inferredcites →https://doi.org/10.1016/j.cgh.2009.04.015openalex-snapshot
Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients With Cirrhosis
inferredcites →https://doi.org/10.1016/j.cgh.2009.11.018openalex-snapshot
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
inferredcites →https://doi.org/10.1016/j.cgh.2013.04.039openalex-snapshot
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
inferredcites →https://doi.org/10.1016/j.clon.2014.04.031openalex-snapshot
Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis
inferredcites →https://doi.org/10.1016/j.crad.2017.07.024openalex-snapshot
Radiofrequency ablation versus resection for hepatocellular carcinoma in patients with Child–Pugh A liver cirrhosis: a meta-analysis
inferredcites →https://doi.org/10.1016/j.ctrv.2007.04.001openalex-snapshot
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome?
inferredcites →https://doi.org/10.1016/j.dld.2008.04.007openalex-snapshot
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.dld.2016.02.005openalex-snapshot
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
inferredcites →https://doi.org/10.1016/j.dld.2016.07.010openalex-snapshot
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.ejca.2005.09.034openalex-snapshot
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level
inferredcites →https://doi.org/10.1016/j.ejca.2008.10.026openalex-snapshot
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
inferredcites →https://doi.org/10.1016/j.ejca.2009.02.018openalex-snapshot
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study
inferredcites →https://doi.org/10.1016/j.ejrad.2011.03.046openalex-snapshot
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
inferredcites →https://doi.org/10.1016/j.ejrad.2011.08.004openalex-snapshot
18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.ejrad.2012.08.012openalex-snapshot
Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma
showing the first 200 of 712 · page through all 712
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4050066openalex-extracted
HAMP Is a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/ags3.12414openalex-snapshot
Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.3230openalex-snapshot
Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.5841openalex-snapshot
Correlation and efficacy of TACE combined with lenvatinib plus PD ‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features
inferred← citeshttps://doi.org/10.1002/cam4.6033openalex-snapshot
Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.34418openalex-snapshot
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high‐risk population: A cross‐sectional study
inferred← citeshttps://doi.org/10.1002/hep.31327openalex-snapshot
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
inferred← citeshttps://doi.org/10.1002/hep4.1847openalex-snapshot
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
inferred← citeshttps://doi.org/10.1002/hep4.2025openalex-snapshot
Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno‐oncology: A network meta‐analysis of randomized sorafenib‐controlled trials
inferred← citeshttps://doi.org/10.1002/ijc.34704openalex-snapshot
Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients
inferred← citeshttps://doi.org/10.1002/jmri.27213openalex-snapshot
Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI : Pitfalls and Potential Tips
inferred← citeshttps://doi.org/10.1002/jmri.28056openalex-snapshot
Modifying LI‐RADS on Gadoxetate Disodium‐Enhanced MRI : A Secondary Analysis of a Prospective Observational Study
inferred← citeshttps://doi.org/10.1002/kjm2.12364openalex-snapshot
Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
inferred← citeshttps://doi.org/10.1002/wjs.12097openalex-snapshot
Advancing complex hepato‐pancreato‐biliary surgery in Uganda: Challenges and outcomes
inferred← citeshttps://doi.org/10.1007/978-3-030-37482-2_7-1openalex-snapshot
Surgical Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-41683-6_7openalex-snapshot
Surgical Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-48767-6_7openalex-snapshot
Hepatocellular Carcinoma: Eastern Experience
inferred← citeshttps://doi.org/10.1007/978-3-030-78737-0_7openalex-snapshot
Overview of Clinical HCC and Its Management
inferred← citeshttps://doi.org/10.1007/978-3-031-09371-5_18openalex-snapshot
“Re-Do” Surgery for Hepatocellular Carcinoma: Indications and Results
inferred← citeshttps://doi.org/10.1007/978-3-031-90225-3_13openalex-snapshot
Can Imaging Findings of Arterial Enhancement and Washout Still Represent a Benign Liver Lesion?
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_11openalex-snapshot
Therapeutic Guidelines for Patients with Liver Cancer from the Perspective of Radiation Oncologists
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_14openalex-snapshot
Definitive Radiotherapy for Locally Advanced Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_15openalex-snapshot
Neoadjuvant Radiotherapy Converting to Curative Resection
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_5openalex-snapshot
Antiviral Therapy in Liver Cancer
inferred← citeshttps://doi.org/10.1007/s00066-019-01570-2openalex-snapshot
Neoadjuvante Radiotherapie verbessert beim resezierbaren hepatozellulären Karzinom mit Portalvenen-Tumorthrombus das Gesamtüberleben und das krankheitsfreie Intervall
inferred← citeshttps://doi.org/10.1007/s00104-020-01118-6openalex-snapshot
Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom
inferred← citeshttps://doi.org/10.1007/s00261-021-03100-0openalex-snapshot
Imaging of treatment response during systemic therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00261-021-03291-6openalex-snapshot
Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study
inferred← citeshttps://doi.org/10.1007/s00261-024-04674-1openalex-snapshot
Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection
inferred← citeshttps://doi.org/10.1007/s00261-024-04729-3openalex-snapshot
International perspectives on LI-RADS
inferred← citeshttps://doi.org/10.1007/s00262-020-02794-3openalex-snapshot
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab
inferred← citeshttps://doi.org/10.1007/s00330-019-06623-9openalex-snapshot
LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features
inferred← citeshttps://doi.org/10.1007/s00330-020-06754-4openalex-snapshot
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1007/s00330-020-06881-yopenalex-snapshot
Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid–enhanced MRI in transplantation candidates
inferred← citeshttps://doi.org/10.1007/s00330-020-07329-zopenalex-snapshot
Subcentimeter hepatocellular carcinoma in treatment-naïve patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid–enhanced MRI
inferred← citeshttps://doi.org/10.1007/s00330-020-07357-9openalex-snapshot
Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00330-020-07468-3openalex-snapshot
Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid–enhanced magnetic resonance imaging
inferred← citeshttps://doi.org/10.1007/s00330-020-07637-4openalex-snapshot
Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging
inferred← citeshttps://doi.org/10.1007/s00330-021-07897-8openalex-snapshot
Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT
inferred← citeshttps://doi.org/10.1007/s00330-021-08124-0openalex-snapshot
A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions
inferred← citeshttps://doi.org/10.1007/s00330-021-08267-0openalex-snapshot
LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
inferred← citeshttps://doi.org/10.1007/s00330-022-08665-yopenalex-snapshot
Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s00330-023-09928-yopenalex-snapshot
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management
inferred← citeshttps://doi.org/10.1007/s00330-023-10135-yopenalex-snapshot
Improving radiomics reproducibility using deep learning-based image conversion of CT reconstruction algorithms in hepatocellular carcinoma patients
inferred← citeshttps://doi.org/10.1007/s00330-026-12820-0openalex-snapshot
Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study
inferred← citeshttps://doi.org/10.1007/s00432-021-03727-yopenalex-snapshot
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00432-021-03788-zopenalex-snapshot
MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety
inferred← citeshttps://doi.org/10.1007/s10620-020-06134-4openalex-snapshot
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study
inferred← citeshttps://doi.org/10.1007/s10620-020-06533-7openalex-snapshot
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1007/s10620-020-06591-xopenalex-snapshot
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
inferred← citeshttps://doi.org/10.1007/s10620-020-06762-wopenalex-snapshot
Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients
inferred← citeshttps://doi.org/10.1007/s10620-021-07312-8openalex-snapshot
Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
inferred← citeshttps://doi.org/10.1007/s11547-024-01879-8openalex-snapshot
LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI
inferred← citeshttps://doi.org/10.1007/s11605-023-05681-1openalex-snapshot
A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s11912-020-00967-yopenalex-snapshot
What’s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update
inferred← citeshttps://doi.org/10.1007/s12029-023-00961-0openalex-snapshot
Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s12072-020-10040-2openalex-snapshot
Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
inferred← citeshttps://doi.org/10.1007/s12072-020-10094-2openalex-snapshot
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
inferred← citeshttps://doi.org/10.1007/s12072-020-10131-0openalex-snapshot
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation
inferred← citeshttps://doi.org/10.1007/s12072-021-10173-yopenalex-snapshot
Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis
inferred← citeshttps://doi.org/10.1007/s12072-021-10184-9openalex-snapshot
Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
inferred← citeshttps://doi.org/10.1007/s12072-021-10190-xopenalex-snapshot
Combined computed tomography and magnetic resonance imaging improves diagnosis of hepatocellular carcinoma ≤ 3.0 cm
inferred← citeshttps://doi.org/10.1007/s12072-021-10205-7openalex-snapshot
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
inferred← citeshttps://doi.org/10.1007/s12072-022-10392-xopenalex-snapshot
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
inferred← citeshttps://doi.org/10.1007/s12664-026-02016-1openalex-snapshot
Albumin-bilirubin grade and sarcopenia as predictors of prognosis in patients with unresectable intermediate and advanced-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s12672-024-01026-9openalex-snapshot
Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s15004-020-8061-0openalex-snapshot
Neoadjuvante RCT verbessert Gesamtüberleben und krankheitsfreies Intervall
inferred← citeshttps://doi.org/10.1007/s15036-020-1324-7openalex-snapshot
Neoadjuvante RCT verbessert Gesamtüberleben und krankheitsfreies Intervall
inferred← citeshttps://doi.org/10.1007/s40477-022-00724-wopenalex-snapshot
High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients
inferred← citeshttps://doi.org/10.1007/s42058-024-00146-zopenalex-snapshot
MRI quantitative hemodynamic parameter histogram assement of hepatocellular carcinoma development in a rabbit VX2 liver cancer model
inferred← citeshttps://doi.org/10.1007/s44343-025-00007-1openalex-snapshot
Hepatobiliary phase abbreviated MRI for secondary surveillance after microwave ablation of HCC
inferred← citeshttps://doi.org/10.1016/b978-0-323-85661-4.00006-8openalex-snapshot
Cancer precision medicine: Focus on gastrointestinal cancer
inferred← citeshttps://doi.org/10.1016/j.acra.2020.06.004openalex-snapshot
Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): An Overview with Technical and Practical Applications
inferred← citeshttps://doi.org/10.1016/j.ajg.2023.12.012openalex-snapshot
Liver imaging reporting and data system diagnostic performance in hepatocellular carcinoma when modifying the definition of “washout” on gadoxetic acid-enhanced magnetic resonance imaging
inferred← citeshttps://doi.org/10.1016/j.annonc.2019.12.001openalex-snapshot
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.02.036openalex-snapshot
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis – A Potential Surveillance Tool?
inferred← citeshttps://doi.org/10.1016/j.clinre.2025.102567openalex-snapshot
Changes in the presentation and characteristics OF HCV related hepatocellular carcinoma in the era of direct acting antiviral therapy: A retrospective study
inferred← citeshttps://doi.org/10.1016/j.clon.2022.02.021openalex-snapshot
Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size
inferred← citeshttps://doi.org/10.1016/j.clon.2023.07.002openalex-snapshot
Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions – A Systematic Review and Network Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ctrv.2023.102526openalex-snapshot
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
inferred← citeshttps://doi.org/10.1016/j.diii.2023.04.007openalex-snapshot
Detection of arterial phase hyperenhancement of small hepatocellular carcinoma with MRI: Comparison between single arterial and multi-arterial phases and between extracellular and hepatospecific contrast agents
inferred← citeshttps://doi.org/10.1016/j.dld.2023.10.029openalex-snapshot
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association…
inferred← citeshttps://doi.org/10.1016/j.ejim.2021.02.019openalex-snapshot
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.hbpd.2021.09.003openalex-snapshot
CK2α causes stemness and chemotherapy resistance in liver cancer through the Hedgehog signaling pathway
inferred← citeshttps://doi.org/10.1016/j.jacr.2021.09.029openalex-snapshot
Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.09.025openalex-snapshot
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.09.026openalex-snapshot
mRECIST for HCC: Performance and novel refinements
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.04.007openalex-snapshot
Selection of MRI contrast agent and diagnostic criteria for HCC to maximize the advantages of contrast agents
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.08.013openalex-snapshot
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.09.026openalex-snapshot
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
inferred← citeshttps://doi.org/10.1016/j.jhep.2021.01.041openalex-snapshot
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jhep.2021.09.025openalex-snapshot
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1016/j.jhepr.2020.100175openalex-snapshot
Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
inferred← citeshttps://doi.org/10.1016/j.jhepr.2022.100594openalex-snapshot
Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jhepr.2023.100991openalex-snapshot
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
inferred← citeshttps://doi.org/10.1016/j.jimed.2020.10.006openalex-snapshot
Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jvir.2020.07.024openalex-snapshot
Benign Biliary Stricture after Yttrium-90 Radioembolization for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.mric.2021.05.005openalex-snapshot
Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance
inferred← citeshttps://doi.org/10.1016/j.mrrev.2021.108374openalex-snapshot
CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations
inferred← citeshttps://doi.org/10.1016/j.radonc.2019.12.004openalex-snapshot
Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.03.027openalex-snapshot
An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective
inferred← citeshttps://doi.org/10.1016/j.rgmx.2022.01.006openalex-snapshot
II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamiento
inferred← citeshttps://doi.org/10.1016/j.rgmxen.2022.01.004openalex-snapshot
The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment
inferred← citeshttps://doi.org/10.1016/j.soc.2023.06.010openalex-snapshot
Overview of Current Hepatocellular Carcinoma Staging Systems
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2023.07.001openalex-snapshot
Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
inferred← citeshttps://doi.org/10.1016/s1470-2045(23)00186-9openalex-snapshot
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
inferred← citeshttps://doi.org/10.1038/s41392-020-00264-xopenalex-snapshot
Targeted therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41392-025-02498-zopenalex-snapshot
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study
inferred← citeshttps://doi.org/10.1038/s41416-020-01249-xopenalex-snapshot
Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
inferred← citeshttps://doi.org/10.1038/s41467-025-59197-0openalex-snapshot
Vision transformer-based model can optimize curative-intent treatment for patients with recurrent hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-019-40078-8openalex-snapshot
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization
inferred← citeshttps://doi.org/10.1038/s41598-021-91021-9openalex-snapshot
The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment
inferred← citeshttps://doi.org/10.1038/s41598-021-91601-9openalex-snapshot
Body weight variability and cancer incidence in men aged 40 years and older-Korean National Insurance Service Cohort
inferred← citeshttps://doi.org/10.1038/s41598-021-92503-6openalex-snapshot
Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-022-11736-1openalex-snapshot
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
inferred← citeshttps://doi.org/10.1038/s43018-023-00618-8openalex-snapshot
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study
inferred← citeshttps://doi.org/10.1055/a-1589-7568openalex-snapshot
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
inferred← citeshttps://doi.org/10.1055/a-2026-1240openalex-snapshot
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
inferred← citeshttps://doi.org/10.1055/s-0044-1786795openalex-snapshot
Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
inferred← citeshttps://doi.org/10.1080/00365521.2020.1866063openalex-snapshot
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal
inferred← citeshttps://doi.org/10.1080/00365521.2022.2093124openalex-snapshot
Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development
inferred← citeshttps://doi.org/10.1080/02656736.2020.1817576openalex-snapshot
Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study
inferred← citeshttps://doi.org/10.1080/07357907.2020.1870126openalex-snapshot
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1080/09553002.2020.1830316openalex-snapshot
Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1080/09553002.2021.1857453openalex-snapshot
Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?
inferred← citeshttps://doi.org/10.1080/17474124.2019.1684898openalex-snapshot
Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy
inferred← citeshttps://doi.org/10.1093/bjs/znab340openalex-snapshot
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study
inferred← citeshttps://doi.org/10.1093/bjsopen/zrac036openalex-snapshot
Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis
inferred← citeshttps://doi.org/10.1097/hep.0000000000000321openalex-snapshot
Adherence to LI-RADS and EASL high-risk population criteria: A systematic review
inferred← citeshttps://doi.org/10.1097/js9.0000000000000295openalex-snapshot
Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial
inferred← citeshttps://doi.org/10.1097/js9.0000000000000873openalex-snapshot
Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study
inferred← citeshttps://doi.org/10.1097/js9.0000000000001950openalex-snapshot
Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and bibliometric analysis
inferred← citeshttps://doi.org/10.1097/md.0000000000026390openalex-snapshot
Clinical outcome and toxicity of radiotherapy for inferior vena cava tumor thrombus in HCC patients
inferred← citeshttps://doi.org/10.1097/md.0000000000026584openalex-snapshot
Microvascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/md.0000000000030918openalex-snapshot
The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation
inferred← citeshttps://doi.org/10.1097/meg.0000000000002058openalex-snapshot
Predicting survival time of Korean hepatocellular carcinoma patients using the Cox proportional hazards model: a retrospective study based on big data analysis
inferred← citeshttps://doi.org/10.1097/meg.0000000000002466openalex-snapshot
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/rli.0000000000000714openalex-snapshot
Added Value of CT Arterial Subtraction Images in Liver Imaging Reporting and Data System Treatment Response Categorization for Transcatheter Arterial Chemoembolization-Treated Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1097/rli.0000000000000910openalex-snapshot
Multiarterial Phase Acquisition in Gadoxetic Acid–Enhanced Liver MRI for the Detection of Hypervascular Hepatocellular Carcinoma in High-Risk Patients
inferred← citeshttps://doi.org/10.1097/sla.0000000000004350openalex-snapshot
Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria
inferred← citeshttps://doi.org/10.1101/2022.07.29.22278175openalex-snapshot
Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocol
inferred← citeshttps://doi.org/10.1111/1751-2980.13172openalex-snapshot
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
inferred← citeshttps://doi.org/10.1111/1754-9485.13309openalex-snapshot
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
inferred← citeshttps://doi.org/10.1111/hepr.14033openalex-snapshot
Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
inferred← citeshttps://doi.org/10.1111/jgh.14848openalex-snapshot
Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/jgh.15175openalex-snapshot
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium
inferred← citeshttps://doi.org/10.1111/jgh.15355openalex-snapshot
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/jgh.15553openalex-snapshot
Use of M2BPGi in HCC patients with TACE
inferred← citeshttps://doi.org/10.1111/jgh.15722openalex-snapshot
Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib
inferred← citeshttps://doi.org/10.1111/jgh.16581openalex-snapshot
Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/jvh.13560openalex-snapshot
Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1111/jvh.13594openalex-snapshot
No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B
inferred← citeshttps://doi.org/10.1111/liv.14835openalex-snapshot
Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease
inferred← citeshttps://doi.org/10.1111/liv.14850openalex-snapshot
Diagnostic performance of MRI using extracellular contrast agents versus gadoxetic acid for hepatocellular carcinoma: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/liv.14883openalex-snapshot
Hepatobiliary contrast agents in MR: Where we stand and future perspectives
inferred← citeshttps://doi.org/10.1111/liv.15052openalex-snapshot
Paradigm shift in the treatment options of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/liv.15110openalex-snapshot
Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients
inferred← citeshttps://doi.org/10.1111/liv.15130openalex-snapshot
Treatment and the prognosis of hepatocellular carcinoma in Asia
inferred← citeshttps://doi.org/10.1111/liv.15632openalex-snapshot
Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
inferred← citeshttps://doi.org/10.1136/bcr-2022-251880openalex-snapshot
Needle tract seeding following percutaneous irreversible electroporation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-067730openalex-snapshot
Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol
inferred← citeshttps://doi.org/10.1136/gutjnl-2020-320692openalex-snapshot
Changing TACTICS in intermediate HCC: TACE plus sorafenib
inferred← citeshttps://doi.org/10.1148/radiol.2020190639openalex-snapshot
Use of Gadoxetic Acid–enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis
inferred← citeshttps://doi.org/10.1155/2020/5860704openalex-snapshot
Regulatory Mechanisms of Coicis Semen on Bionetwork of Liver Cancer Based on Network Pharmacology
inferred← citeshttps://doi.org/10.1155/2021/6640121openalex-snapshot
Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
inferred← citeshttps://doi.org/10.1155/2021/8943353openalex-snapshot
Application of NRS2002 in Preoperative Nutritional Screening for Patients with Liver Cancer
inferred← citeshttps://doi.org/10.11569/wcjd.v29.i4.182openalex-snapshot
Effects of camrelizumab combined with transcatheter arterial chemoembolization arterial chemoembolization on serum Egfl7, VEGF, and OPN levels and recurrence rate in patients with hepatocellular carcinoma with microvascular invasion after radical operation: A prospective study
inferred← citeshttps://doi.org/10.1159/000502905openalex-snapshot
A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE
inferred← citeshttps://doi.org/10.1159/000505696openalex-snapshot
A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000507370openalex-snapshot
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
inferred← citeshttps://doi.org/10.1159/000507934openalex-snapshot
A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000510909openalex-snapshot
Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes
inferred← citeshttps://doi.org/10.1159/000516613openalex-snapshot
Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
inferred← citeshttps://doi.org/10.1159/000518837openalex-snapshot
Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study
inferred← citeshttps://doi.org/10.1159/000521227openalex-snapshot
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy
inferred← citeshttps://doi.org/10.1159/000521827openalex-snapshot
Surgical Resection Is Preferred in Selected Solitary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
inferred← citeshttps://doi.org/10.1159/000525518openalex-snapshot
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
inferred← citeshttps://doi.org/10.1159/000529635openalex-snapshot
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
inferred← citeshttps://doi.org/10.1159/000534513openalex-snapshot
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
inferred← citeshttps://doi.org/10.1159/000546899openalex-snapshot
Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study
inferred← citeshttps://doi.org/10.11622/smedj.2022092openalex-snapshot
Referring clinicians’ knowledge, attitudes and practice towards international guidelines for liver cancer diagnosis in Singapore
inferred← citeshttps://doi.org/10.1177/02841851231203830openalex-snapshot
LI-RADS category 3, 4, and M observations: a multiple parameters diagnostic model for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1177/0300060520930151openalex-snapshot
Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients
inferred← citeshttps://doi.org/10.1177/10732748211039758openalex-snapshot
Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus
inferred← citeshttps://doi.org/10.1177/15330338241256859openalex-snapshot
Based on Gadolinium Ethoxybenzyl DTPA–Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1177/1557988320908102openalex-snapshot
Incidental Gynecomastia on Thoracic Computed Tomography in Clinical Practice: Characteristics, Radiologic Features, and Correlation With Possible Causes in South Korean Men
inferred← citeshttps://doi.org/10.1186/s12876-021-01833-2openalex-snapshot
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/s12876-022-02182-4openalex-snapshot
Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data
inferred← citeshttps://doi.org/10.1186/s12876-023-02750-2openalex-snapshot
The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
inferred← citeshttps://doi.org/10.1186/s12885-025-14683-yopenalex-snapshot
Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/s13046-020-01603-0openalex-snapshot
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
inferred← citeshttps://doi.org/10.1186/s40644-022-00497-9openalex-snapshot
Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation
inferred← citeshttps://doi.org/10.1259/bjr.20220179openalex-snapshot
Summary of key guidelines for locoregional treatment of HCC in Asia, Europe, South and North America
inferred← citeshttps://doi.org/10.12701/yujm.2019.00269openalex-snapshot
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.12965/jer.2550482.241openalex-snapshot
Spectrum of therapeutic options in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.12998/wjcc.v10.i8.2591openalex-snapshot
Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature
inferred← citeshttps://doi.org/10.13104/imri.2021.25.3.172openalex-snapshot
LI-RADS version 2018 in Patients with Prior History of Hepatocellular Carcinoma: Are LR4 Observations Enough for the Diagnosis of Recurrent HCC?
inferred← citeshttps://doi.org/10.1371/journal.pone.0249003openalex-snapshot
A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness
showing the first 200 of 389 · page through all 389
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.